The Gamaleya Center announced the effectiveness of a new vaccine against swine flu

Nasal vaccine of the N.F. Gamaleya against influenza will be effective against various strains, including swine influenza A (H1N1), director of the center Alexander Gintsburg told Izvestia.

“The design features of the nasal vaccine are such that protection will be formed against different strains of influenza A, whether it be H1N1 swine flu or bird flu. It will also protect against types of influenza type B, which are annually included in the classic vaccines, ”the developer of the drug, head of the laboratory of molecular biotechnology at the Center for them, explained to the newspaper. Gamalei, Doctor of Biological Sciences Maxim Shmarov.

The new vaccine is called GamFluVak-Kvadri. The drug is made in the form of a solution that is injected through the nose. This is a quadrivalent vector vaccine (the “deliverers” of the drug are four human adenoviruses), created by the type of the Sputnik V vaccine against COVID-19 .

The first phase of clinical trials of the vaccine, which was approved by the Ministry of Health, began on September 28, follows from the information in the State Register of Medicines. The study will involve 45 people and will evaluate the safety, reactogenicity and immunogenicity of the vaccine in healthy volunteers. The two-phase trial of the drug is due to end on December 31st.

According to Shmarov, the first stage is going well, and no negative side effects were registered in the volunteers after the administration of the drug. In the next six months, the vaccinated will be monitored. Preliminary results of the first stage of clinical trials of the nasal vaccine have not yet been published, they should be made public in three months.

The Ministry of Health recommended that Russians wear masks Society

The incidence of influenza and SARS in Russia continues to grow, the Rospotrebnadzor reported yesterday. According to the agency, over the past week, the incidence rate has increased by 23.3% compared with the previous week. Swine influenza A (H1N1) was detected in 74 regions.

Read on RBC Pro Exit to Ozon: what mistakes a novice seller is quite able to avoid Urgently and with a discount of up to 25%: how mobilization has changed the real estate market Not to fat: why overweight employees are oppressed in Russia 10 phrases,who say that you are not going to return the money

More than 72.4 million people, or 49.5% of the country's population, have been vaccinated against influenza, according to Rospotrebnadzor. As of December 2, Tyva became the leader in terms of the share of the vaccinated population (61.5%), followed by Chechnya (60.5%) and the Khanty-Mansiysk Autonomous Okrug - Yugra (60.4%). In Moscow, 54.5% of residents were vaccinated, in St. Petersburg - 58%.